Xiaodong Duan , Yongan Deng , Minghao Feng , Chengkai Chen , Simin Yang , Shuting Zeng , Xiaodie Chen , Nan Xiao , Xiangyu Chen , Jianhua Li , Yixuan Huang , Yutong Yang , Min Yu , Guangwei Wang , Wenrong Yu , Li Zhang , Yi Wang , Zunpeng Shu
{"title":"补阳还五汤延缓心脏衰老的潜在分子机制:基于网络药理学、生物信息学和体内/体外实验验证。","authors":"Xiaodong Duan , Yongan Deng , Minghao Feng , Chengkai Chen , Simin Yang , Shuting Zeng , Xiaodie Chen , Nan Xiao , Xiangyu Chen , Jianhua Li , Yixuan Huang , Yutong Yang , Min Yu , Guangwei Wang , Wenrong Yu , Li Zhang , Yi Wang , Zunpeng Shu","doi":"10.1016/j.jep.2025.120624","DOIUrl":null,"url":null,"abstract":"<div><h3>Ethnopharmacological relevance</h3><div>Cardiac aging is closely associated with the occurrence and progression of various cardiovascular diseases (CVD). Buyang Huanwu Decoction (BYHWD), a classical traditional Chinese medicine formula, is widely used clinically for cerebrovascular and cardiovascular diseases. However, its role in delaying cardiac aging and the underlying molecular mechanisms remain unclear.</div></div><div><h3>Aim of the study</h3><div>This study aimed to investigate the role of BYHWD in cardiac aging and explore its potential molecular mechanisms.</div></div><div><h3>Materials and methods</h3><div>D-galactose (D-gal) was used to establish <em>in vivo</em> and <em>in vitro</em> aging models, with BYHWD administered as an intervention. Histopathological examination and biochemical assays assessed cardiac tissue damage, and Western blot detected aging-related markers. Untargeted metabolomics and network pharmacology identified potential targets and pathways. Finally, molecular biology methods such as RT-qPCR, Immunohistochemistry, and Western blot were used to validate the expression levels of genes and proteins in key pathways.</div></div><div><h3>Results</h3><div>BYHWD effectively alleviated cardiac pathological injury, significantly inhibited the mRNA levels of pro-inflammatory factors <em>Il-1β</em>, <em>Il-6</em>, and <em>Tnf-α</em> in cardiac tissues, and downregulated the expression of senescence-related proteins p16, p21, and p53. Untargeted metabolomics analysis revealed that BYHWD might restore metabolic disorders in the hearts of aging rats by regulating energy and amino acid metabolism pathways. Network pharmacology analysis demonstrated that BYHWD might delay cardiac aging by modulating immune and inflammatory responses, with the CaM/CaMKII/MAPK pathway being significantly enriched in its mechanism of action. RT-qPCR, Immunohistochemistry, and Western blot further confirmed that BYHWD exerted its anti-aging effects on the heart by inhibiting the CaM/CaMKII/MAPK pathway.</div></div><div><h3>Conclusion</h3><div>BYHWD was found to effectively delay D-gal-induced aging in both rat hearts and cardiomyocytes. Mechanistically, BYHWD modulated energy and amino acid metabolic pathways while inhibiting the CaM/CaMKII/MAPK axis to exert anti-inflammatory effects. Overall, this study provides novel insights into the mechanisms through which BYHWD delays cardiac aging.</div></div>","PeriodicalId":15761,"journal":{"name":"Journal of ethnopharmacology","volume":"355 ","pages":"Article 120624"},"PeriodicalIF":5.4000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Elucidation of the potential molecular mechanisms of Buyang Huanwu Decoction in delaying cardiac aging: Based on network pharmacology, bioinformatics, and in vivo/in vitro experimental validation\",\"authors\":\"Xiaodong Duan , Yongan Deng , Minghao Feng , Chengkai Chen , Simin Yang , Shuting Zeng , Xiaodie Chen , Nan Xiao , Xiangyu Chen , Jianhua Li , Yixuan Huang , Yutong Yang , Min Yu , Guangwei Wang , Wenrong Yu , Li Zhang , Yi Wang , Zunpeng Shu\",\"doi\":\"10.1016/j.jep.2025.120624\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Ethnopharmacological relevance</h3><div>Cardiac aging is closely associated with the occurrence and progression of various cardiovascular diseases (CVD). Buyang Huanwu Decoction (BYHWD), a classical traditional Chinese medicine formula, is widely used clinically for cerebrovascular and cardiovascular diseases. However, its role in delaying cardiac aging and the underlying molecular mechanisms remain unclear.</div></div><div><h3>Aim of the study</h3><div>This study aimed to investigate the role of BYHWD in cardiac aging and explore its potential molecular mechanisms.</div></div><div><h3>Materials and methods</h3><div>D-galactose (D-gal) was used to establish <em>in vivo</em> and <em>in vitro</em> aging models, with BYHWD administered as an intervention. Histopathological examination and biochemical assays assessed cardiac tissue damage, and Western blot detected aging-related markers. Untargeted metabolomics and network pharmacology identified potential targets and pathways. Finally, molecular biology methods such as RT-qPCR, Immunohistochemistry, and Western blot were used to validate the expression levels of genes and proteins in key pathways.</div></div><div><h3>Results</h3><div>BYHWD effectively alleviated cardiac pathological injury, significantly inhibited the mRNA levels of pro-inflammatory factors <em>Il-1β</em>, <em>Il-6</em>, and <em>Tnf-α</em> in cardiac tissues, and downregulated the expression of senescence-related proteins p16, p21, and p53. Untargeted metabolomics analysis revealed that BYHWD might restore metabolic disorders in the hearts of aging rats by regulating energy and amino acid metabolism pathways. Network pharmacology analysis demonstrated that BYHWD might delay cardiac aging by modulating immune and inflammatory responses, with the CaM/CaMKII/MAPK pathway being significantly enriched in its mechanism of action. RT-qPCR, Immunohistochemistry, and Western blot further confirmed that BYHWD exerted its anti-aging effects on the heart by inhibiting the CaM/CaMKII/MAPK pathway.</div></div><div><h3>Conclusion</h3><div>BYHWD was found to effectively delay D-gal-induced aging in both rat hearts and cardiomyocytes. Mechanistically, BYHWD modulated energy and amino acid metabolic pathways while inhibiting the CaM/CaMKII/MAPK axis to exert anti-inflammatory effects. Overall, this study provides novel insights into the mechanisms through which BYHWD delays cardiac aging.</div></div>\",\"PeriodicalId\":15761,\"journal\":{\"name\":\"Journal of ethnopharmacology\",\"volume\":\"355 \",\"pages\":\"Article 120624\"},\"PeriodicalIF\":5.4000,\"publicationDate\":\"2025-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of ethnopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0378874125013169\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of ethnopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378874125013169","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Elucidation of the potential molecular mechanisms of Buyang Huanwu Decoction in delaying cardiac aging: Based on network pharmacology, bioinformatics, and in vivo/in vitro experimental validation
Ethnopharmacological relevance
Cardiac aging is closely associated with the occurrence and progression of various cardiovascular diseases (CVD). Buyang Huanwu Decoction (BYHWD), a classical traditional Chinese medicine formula, is widely used clinically for cerebrovascular and cardiovascular diseases. However, its role in delaying cardiac aging and the underlying molecular mechanisms remain unclear.
Aim of the study
This study aimed to investigate the role of BYHWD in cardiac aging and explore its potential molecular mechanisms.
Materials and methods
D-galactose (D-gal) was used to establish in vivo and in vitro aging models, with BYHWD administered as an intervention. Histopathological examination and biochemical assays assessed cardiac tissue damage, and Western blot detected aging-related markers. Untargeted metabolomics and network pharmacology identified potential targets and pathways. Finally, molecular biology methods such as RT-qPCR, Immunohistochemistry, and Western blot were used to validate the expression levels of genes and proteins in key pathways.
Results
BYHWD effectively alleviated cardiac pathological injury, significantly inhibited the mRNA levels of pro-inflammatory factors Il-1β, Il-6, and Tnf-α in cardiac tissues, and downregulated the expression of senescence-related proteins p16, p21, and p53. Untargeted metabolomics analysis revealed that BYHWD might restore metabolic disorders in the hearts of aging rats by regulating energy and amino acid metabolism pathways. Network pharmacology analysis demonstrated that BYHWD might delay cardiac aging by modulating immune and inflammatory responses, with the CaM/CaMKII/MAPK pathway being significantly enriched in its mechanism of action. RT-qPCR, Immunohistochemistry, and Western blot further confirmed that BYHWD exerted its anti-aging effects on the heart by inhibiting the CaM/CaMKII/MAPK pathway.
Conclusion
BYHWD was found to effectively delay D-gal-induced aging in both rat hearts and cardiomyocytes. Mechanistically, BYHWD modulated energy and amino acid metabolic pathways while inhibiting the CaM/CaMKII/MAPK axis to exert anti-inflammatory effects. Overall, this study provides novel insights into the mechanisms through which BYHWD delays cardiac aging.
期刊介绍:
The Journal of Ethnopharmacology is dedicated to the exchange of information and understandings about people''s use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions. Early people confronted with illness and disease, discovered a wealth of useful therapeutic agents in the plant and animal kingdoms. The empirical knowledge of these medicinal substances and their toxic potential was passed on by oral tradition and sometimes recorded in herbals and other texts on materia medica. Many valuable drugs of today (e.g., atropine, ephedrine, tubocurarine, digoxin, reserpine) came into use through the study of indigenous remedies. Chemists continue to use plant-derived drugs (e.g., morphine, taxol, physostigmine, quinidine, emetine) as prototypes in their attempts to develop more effective and less toxic medicinals.